Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration

Dry Macular Degeneration Clinical Trial

Official title:
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Injected Intravitreal in Dry Macular Degeneration

Status Withdrawn

Clinical Trial Summary

This will be an open-label, non-randomized multi-center study of adipose stem cell (ASC) implantation. ASCs will be derived from the patient's adipose or fat. Liposuction using local anesthesia and syringe collection will be performed to collect the adipose tissue specimen for subsequent processing to isolate the stem cells. The cells will be delivered via needle injection into the eye.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02024269
Study type	Interventional
Source	Bioheart, Inc.
Contact
Status	Withdrawn
Phase	N/A
Start date	December 2013
Completion date	June 2017

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02699216` - BioCurrent Electrical Stimulation for the Treatment of Dry ARMD	N/A
Recruiting	`NCT04469140` - Non Exudative AMD Imaged With SS-OCT- Extension
Active, not recruiting	`NCT03688243` - Non Exudative AMD Imaged With SS-OCT
Active, not recruiting	`NCT02590692` - Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD	Phase 1/Phase 2
Completed	`NCT02684578` - Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD	Phase 2